JPS6259118B2 - - Google Patents
Info
- Publication number
- JPS6259118B2 JPS6259118B2 JP14660281A JP14660281A JPS6259118B2 JP S6259118 B2 JPS6259118 B2 JP S6259118B2 JP 14660281 A JP14660281 A JP 14660281A JP 14660281 A JP14660281 A JP 14660281A JP S6259118 B2 JPS6259118 B2 JP S6259118B2
- Authority
- JP
- Japan
- Prior art keywords
- glycyrrhizin
- solution
- urea
- water
- room temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 67
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 67
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 67
- 239000004378 Glycyrrhizin Substances 0.000 claims description 66
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 66
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 66
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 21
- 239000004202 carbamide Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 17
- 239000004299 sodium benzoate Substances 0.000 claims description 17
- 235000010234 sodium benzoate Nutrition 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 11
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 239000003002 pH adjusting agent Substances 0.000 claims description 4
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 229940010454 licorice Drugs 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims 2
- 239000000243 solution Substances 0.000 description 38
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000003929 acidic solution Substances 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 239000003513 alkali Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000003204 osmotic effect Effects 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 229940097043 glucuronic acid Drugs 0.000 description 2
- 239000007951 isotonicity adjuster Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229930002879 flavonoid pigment Natural products 0.000 description 1
- 150000004638 flavonoid pigments Chemical class 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- -1 glycyrrhizin monopotassium salt Chemical class 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14660281A JPS5849310A (ja) | 1981-09-17 | 1981-09-17 | 有用なるグリチルリチン溶液の調製法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14660281A JPS5849310A (ja) | 1981-09-17 | 1981-09-17 | 有用なるグリチルリチン溶液の調製法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5849310A JPS5849310A (ja) | 1983-03-23 |
| JPS6259118B2 true JPS6259118B2 (enrdf_load_stackoverflow) | 1987-12-09 |
Family
ID=15411430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14660281A Granted JPS5849310A (ja) | 1981-09-17 | 1981-09-17 | 有用なるグリチルリチン溶液の調製法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5849310A (enrdf_load_stackoverflow) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2616800B1 (fr) * | 1987-06-16 | 1990-01-12 | Pernod Ricard | Production d'une enzyme du type bglucuronidase, hydrolyse de la glycyrrhizine et production d'acide 18 b-glycyrrhetinique |
| WO2005014009A1 (ja) * | 2003-08-12 | 2005-02-17 | Nippon Zoki Pharmaceutical Co., Ltd. | グリチルリチン高濃度製剤 |
| CN104072572B (zh) * | 2014-07-21 | 2016-08-24 | 江苏天晟药业有限公司 | 一种甘草次酸钠及其制备方法 |
-
1981
- 1981-09-17 JP JP14660281A patent/JPS5849310A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5849310A (ja) | 1983-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4749707A (en) | Citric acid salt of (+) vinpocetine | |
| KR930001915A (ko) | 췌장섬유증과 만성동통 증후군의 치료에 적합한 제약조성물과 그의 제조방법 및 용도 | |
| DE3151196A1 (de) | Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen | |
| DE69016541T2 (de) | Nichtsprudelnde Ibuprofen-Zusammensetzungen. | |
| FI120080B (fi) | Farmaseuttisia koostumuksia, joilla on antibioottinen vaikutus | |
| JPH0154338B2 (enrdf_load_stackoverflow) | ||
| US3830824A (en) | Physiological organic acid silver allantoinates | |
| GB1572137A (en) | Stable compositions for therapeutic use based on d,1-5-methyltetrahydrofolic acid and its salts | |
| JPS6259118B2 (enrdf_load_stackoverflow) | ||
| IE51568B1 (en) | Vincamine saccharinate and pharmaceutical compositions containing same | |
| US7109373B2 (en) | Creatine salts and method of making same | |
| US3767803A (en) | Stable aqueous pyritinol solutions | |
| US3751564A (en) | Process for preparing scleroprotein-alkyl thiosulfate agents for the care of the hair | |
| GB1498160A (en) | Agent for skin treatment and a wet diaper prepared therewith | |
| US2434625A (en) | Preparation of alkali metal ascorbates | |
| US3809759A (en) | Pharmaceutical composition for treating mental fatigue containing arginine-potassium phospho citro glutamate and method of using the same | |
| US3542929A (en) | Chemotherapeutic compositions useful in animal detoxification | |
| DE2706841C2 (enrdf_load_stackoverflow) | ||
| US2449041A (en) | Riboflavin solutions | |
| GB1564135A (en) | Readily-assimilatable highly-soluble calcium and/or magnesium organic salts | |
| JPH026335B2 (enrdf_load_stackoverflow) | ||
| JPS61143345A (ja) | メナジオンコリン重亜硫酸付加物及びその製法 | |
| JPH0414646B2 (enrdf_load_stackoverflow) | ||
| JPS60163897A (ja) | ウルソデオキシコ−ル酸メグルミン塩およびその注射剤 | |
| JPS61218522A (ja) | 中性乃至弱アルカリ性で安定な水酸化鉄コロイド溶液 |